Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) EPS (Basic): 2009-2025

Historic EPS (Basic) for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -$1.27.

  • Lifecore Biomedical's EPS (Basic) rose 87.50% to -$0.03 in Q2 2025 from the same period last year, while for May 2025 it was -$1.28, marking a year-over-year decrease of 487.88%. This contributed to the annual value of -$1.27 for FY2025, which is 425.64% down from last year.
  • Latest data reveals that Lifecore Biomedical reported EPS (Basic) of -$1.27 as of FY2025, which was down 425.64% from $0.39 recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's EPS (Basic) registered a high of $0.39 during FY2024, and its lowest value of -$3.97 during FY2022.
  • Moreover, its 3-year median value for EPS (Basic) was -$1.27 (2025), whereas its average is -$1.40.
  • As far as peak fluctuations go, Lifecore Biomedical's EPS (Basic) soared by 111.75% in 2024, and later slumped by 425.64% in 2025.
  • Yearly analysis of 5 years shows Lifecore Biomedical's EPS (Basic) stood at -$1.10 in 2021, then tumbled by 260.91% to -$3.97 in 2022, then increased by 16.37% to -$3.32 in 2023, then spiked by 111.75% to $0.39 in 2024, then slumped by 425.64% to -$1.27 in 2025.